Post-translationally modified T cell epitopes: Immune recognition and immunotherapy

Journal of Molecular Medicine

Volumn 87, Issue 11, 2009, Pages 1045-1051

  Petersen, Jan ^a   Purcell, Anthony W ^b   Rossjohn, Jamie ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Immunity; Major histocompatibility antigen complex; Post translational modification; T cell receptor

Indexed keywords

ASPARTIC ACID; CITRULLINE; DISULFIDE; EPITOPE; PEPTIDOMIMETIC AGENT;

ACETYLATION; ALKYLATION; ANTIGEN RECOGNITION; DEAMINATION; DISULFIDE BOND; GLYCOSYLATION; HUMAN; HYDROXYLATION; IMMUNOTHERAPY; IN VIVO STUDY; ISOMERIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; METHYLATION; NITRATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SULFATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 70449520994     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-009-0526-4     Document Type: Review

References (57)

1. M Mann ON Jensen 2003 Proteomic analysis of post-translational modifications Nat Biotechnol 21 255 261 10.1038/nbt0303-255 1:CAS:528: DC%2BD3sXhsFajsro%3D 12610572 (Pubitemid 36314808)
2. KE Krueger S Srivastava 2006 Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics Mol Cell Proteomics 5 1799 1810 10.1074/mcp.R600009-MCP200 1:CAS:528:DC%2BD28XhtFGqsbbP 16844681 (Pubitemid 44688189)
3. MZ Atassi P Casali 2008 Molecular mechanisms of autoimmunity Autoimmunity 41 123 132 10.1080/08916930801929021 1:CAS:528:DC%2BD1cXivVaku70%3D 18324481
4. C Hetzer W Dormeyer M Schnolzer M Ott 2005 Decoding Tat: the biology of HIV Tat posttranslational modifications Microbes Infect 7 1364 1369 10.1016/j.micinf.2005.06.003 1:CAS:528:DC%2BD2MXht1Sksb7M 16046164 (Pubitemid 41572313)
5. SM Anderton 2004 Post-translational modifications of self antigens: implications for autoimmunity Curr Opin Immunol 16 753 758 10.1016/j.coi.2004. 09.001 1:CAS:528:DC%2BD2cXptFyjt78%3D 15511669 (Pubitemid 39423665)
6. AW Purcell J McCluskey J Rossjohn 2007 More than one reason to rethink the use of peptides in vaccine design Nat Rev Drug Discov 6 404 414 10.1038/nrd2224 1:CAS:528:DC%2BD2sXkslyiu7s%3D 17473845 (Pubitemid 46696551)
7. AR Ferguson LA Nichols AL Zarling ED Thompson CC Brinkman KM Hargadon TN Bullock VH Engelhard 2008 Strategies and challenges in eliciting immunity to melanoma Immunol Rev 222 28 42 10.1111/j.1600-065X.2008.00620.x 1:CAS:528:DC%2BD1cXlsFejtrw%3D 18363993
8. VH Engelhard M Altrich-Vanlith M Ostankovitch AL Zarling 2006 Post-translational modifications of naturally processed MHC-binding epitopes Curr Opin Immunol 18 92 97 10.1016/j.coi.2005.11.015 1:CAS:528: DC%2BD28XhvFOgug%3D%3D 16343885 (Pubitemid 43049654)
9. AW Purcell IR van Driel PA Gleeson 2008 Impact of glycans on T-cell tolerance to glycosylated self-antigens Immunol Cell Biol 86 574 579 10.1038/icb.2008.48 1:CAS:528:DC%2BD1cXhtF2jsr7P 18626489
10. PJ Lehner P Cresswell 2004 Recent developments in MHC-class-I-mediated antigen presentation Curr Opin Immunol 16 82 89 10.1016/j.coi.2003.11.012 1:CAS:528:DC%2BD2cXltFaitg%3D%3D 14734114 (Pubitemid 38198121)
11. VH Engelhard AG Brickner AL Zarling 2002 Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire Mol Immunol 39 127 137 10.1016/S0161-5890(02)00096-2 1:CAS:528:DC%2BD38XmsVWqtLg%3D 12200045 (Pubitemid 35013506)
12. JS Haurum IB Hoier G Arsequell A Neisig G Valencia J Zeuthen J Neefjes T Elliott 1999 Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo J Exp Med 190 145 150 10.1084/jem.190.1.145 1:CAS:528:DyaK1MXksVeiu7g%3D 10429679 (Pubitemid 29330132)
13. IB Kastrup S Stevanovic G Arsequell G Valencia J Zeuthen HG Rammensee T Elliott JS Haurum 2000 Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo Tissue Antigens 56 129 135 10.1034/j.1399-0039.2000.560203.x 1:CAS:528:DC%2BD3cXmsFOgsrg%3D 11019912 (Pubitemid 30621278)
14. AL Zarling SB Ficarro FM White J Shabanowitz DF Hunt VH Engelhard 2000 Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo J Exp Med 192 1755 1762 10.1084/jem.192.12.1755 1:CAS:528:DC%2BD3cXptVKmsbg%3D 11120772 (Pubitemid 32049768)
15. J Yague J Vazquez JA Lopez de Castro 2000 A post-translational modification of nuclear proteins, N(G), N(G)-dimethyl-Arg, found in a natural HLA class I peptide ligand Protein Sci 9 2210 2217 10.1110/ps.9.11.2210 1:CAS:528:DC%2BD3MXhsFOhuw%3D%3D 11152131
16. MG Rudolph RL Stanfield IA Wilson 2006 How TCRs bind MHCs, peptides, and coreceptors Annu Rev Immunol 24 419 466 10.1146/annurev.immunol.23.021704.115658 1:CAS:528:DC%2BD28XkvFSqtLw%3D 16551255
17. DI Godfrey J Rossjohn J McCluskey 2008 The fidelity, occasional promiscuity, and versatility of T cell receptor recognition Immunity 28 304 314 10.1016/j.immuni.2008.02.004 1:CAS:528:DC%2BD1cXjvFeksL8%3D 18342005 (Pubitemid 351343861)
18. CS Clements MA Dunstone WA Macdonald J McCluskey J Rossjohn 2006 Specificity on a knife-edge: the alphabeta T cell receptor Curr Opin Struct Biol 16 787 795 10.1016/j.sbi.2006.09.004 1:CAS:528:DC%2BD28Xht1OhtL%2FI 17011774 (Pubitemid 44827723)
19. J Dengjel HG Rammensee S Stevanovic 2005 Glycan side chains on naturally presented MHC class II ligands J Mass Spectrom 40 100 104 10.1002/jms.780 1:CAS:528:DC%2BD2MXht1Wksr4%3D 15643650 (Pubitemid 40188986)
20. AL Zarling JM Polefrone AM Evans LM Mikesh J Shabanowitz ST Lewis VH Engelhard DF Hunt 2006 Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy Proc Natl Acad Sci U S A 103 14889 14894 10.1073/pnas.0604045103 1:CAS:528:DC%2BD28XhtVyhtbnE 17001009 (Pubitemid 44527824)
21. K Engelmann H Shen OJ Finn 2008 MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1 Cancer Res 68 2419 2426 10.1158/0008-5472.CAN-07-2249 1:CAS:528: DC%2BD1cXktV2js7w%3D 18381450
22. FG Hanisch T Ninkovic 2006 Immunology of O-glycosylated proteins: approaches to the design of a MUC1 glycopeptide-based tumor vaccine Curr Protein Pept Sci 7 307 315 10.2174/138920306778018034 1:CAS:528:DC%2BD28XnvFaisb4%3D 16918445 (Pubitemid 44237140)
23. SO Ryan AM Vlad K Islam J Gariepy OJ Finn 2009 Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice Biol Chem 390 611 618 10.1515/BC.2009.070 1:CAS:528:DC%2BD1MXotlGjtLs%3D 19426130
24. Ninkovic T, Kinarsky L, Engelmann K, Pisarev V, Sherman S, Finn OJ, Hanisch FG (2008) Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes. Mol Immunol. doi: 10.1016/j.molimm.2008.09.032
25. ML Altrich-VanLith M Ostankovitch JM Polefrone CA Mosse J Shabanowitz DF Hunt VH Engelhard 2006 Processing of a class I-restricted epitope from tyrosinase requires peptide N-glycanase and the cooperative action of endoplasmic reticulum aminopeptidase 1 and cytosolic proteases J Immunol 177 5440 5450 1:CAS:528:DC%2BD28XhtVansrbE 17015730
26. E Kario B Tirosh HL Ploegh A Navon 2008 N-linked glycosylation does not impair proteasomal degradation but affects class I major histocompatibility complex presentation J Biol Chem 283 244 254 10.1074/jbc.M706237200 1:CAS:528:DC%2BD1cXhtVOltQ%3D%3D 17951257
27. M Ostankovitch M Altrich-Vanlith V Robila VH Engelhard 2009 N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase J Immunol 182 4830 4835 10.4049/jimmunol.0802902 1:CAS:528: DC%2BD1MXjvFOjurk%3D 19342661
28. A Corthay J Backlund J Broddefalk E Michaelsson TJ Goldschmidt J Kihlberg R Holmdahl 1998 Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis Eur J Immunol 28 2580 2590 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0. CO;2-X 1:CAS:528:DyaK1cXlt1Shtbw%3D 9710235 (Pubitemid 28362732)
29. J Backlund S Carlsen T Hoger B Holm L Fugger J Kihlberg H Burkhardt R Holmdahl 2002 Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis Proc Natl Acad Sci U S A 99 9960 9965 10.1073/pnas. 132254199 1:CAS:528:DC%2BD38XlslKgtrw%3D 12089323 (Pubitemid 34831155)
30. B Dzhambazov M Holmdahl H Yamada S Lu M Vestberg B Holm O Johnell J Kihlberg R Holmdahl 2005 The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans Eur J Immunol 35 357 366 10.1002/eji.200425637 1:CAS:528: DC%2BD2MXhvFKmu7o%3D 15682451 (Pubitemid 40331311)
31. I Gjertsson KL Laurie J Devitt SJ Howe AJ Thrasher R Holmdahl K Gustafsson 2009 Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis Mol Ther 17 632 640 10.1038/mt.2009.299 1:CAS:528:DC%2BD1MXhtVent78%3D 19174762
32. B Dzhambazov KS Nandakumar J Kihlberg L Fugger R Holmdahl M Vestberg 2006 Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules J Immunol 176 1525 1533 1:CAS:528:DC%2BD28XlsFygtw%3D%3D 16424181
33. RS Green EL Stone M Tenno E Lehtonen MG Farquhar JD Marth 2007 Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis Immunity 27 308 320 10.1016/j.immuni.2007.06.008 1:CAS:528:DC%2BD2sXhtVSgtb3L 17681821 (Pubitemid 47284915)
34. H Li CF Xu S Blais Q Wan HT Zhang SJ Landry CE Hioe 2009 Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes J Immunol 182 6369 6378 10.4049/jimmunol.0804287 1:CAS:528:DC%2BD1MXltlymsrk%3D 19414790
35. VS Meyer O Drews M Gunder J Hennenlotter HG Rammensee S Stevanovic 2009 Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands J Proteome Res 8 3666 3674 10.1021/pr800937k 1:CAS:528:DC%2BD1MXmtF2ksbc%3D 19415920
36. F Mohammed M Cobbold AL Zarling M Salim GA Barrett-Wilt J Shabanowitz DF Hunt VH Engelhard BE Willcox 2008 Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self Nat Immunol 9 1236 1243 10.1038/ni.1660 1:CAS:528: DC%2BD1cXht1KrtbjM 18836451
37. J Petersen SJ Wurzbacher NA Williamson SH Ramarathinam HH Reid AK Nair AY Zhao R Nastovska G Rudge J Rossjohn AW Purcell 2009 Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes Proc Natl Acad Sci U S A 106 2776 2781 10.1073/pnas.0812901106 1:CAS:528:DC%2BD1MXislahtrY%3D 19196958
38. B Gyorgy E Toth E Tarcsa A Falus EI Buzas 2006 Citrullination: a posttranslational modification in health and disease Int J Biochem Cell Biol 38 1662 1677 10.1016/j.biocel.2006.03.008 16730216 (Pubitemid 43947646)
39. JA Hill DA Bell W Brintnell D Yue B Wehrli AM Jevnikar DM Lee W Hueber WH Robinson E Cairns 2008 Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice J Exp Med 205 967 979 10.1084/jem.20072051 1:CAS:528:DC%2BD1cXkvVyrs7g%3D 18391064 (Pubitemid 351549891)
40. G Harauz AA Musse 2007 A tale of two citrullines-structural and functional aspects of myelin basic protein deimination in health and disease Neurochem Res 32 137 158 10.1007/s11064-006-9108-9 1:CAS:528: DC%2BD2sXhsVyqs7w%3D 16900293 (Pubitemid 46238860)
41. BA Kidd PP Ho O Sharpe X Zhao BH Tomooka JL Kanter L Steinman WH Robinson 2008 Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination Arthritis Res Ther 10 R119 10.1186/ar2523 18826638
42. HK Kang JA Mikszta H Deng EE Sercarz PE Jensen BS Kim 2000 Processing and reactivity of T cell epitopes containing two cysteine residues from hen egg-white lysozyme (HEL74-90) J Immunol 164 1775 1782 1:CAS:528: DC%2BD3cXhtlymt74%3D 10657624
43. P Li MA Haque JS Blum 2002 Role of disulfide bonds in regulating antigen processing and epitope selection J Immunol 169 2444 2450 1:CAS:528: DC%2BD38XmsF2gur4%3D 12193713
44. M Hensmann C Li C Moss V Lindo F Greer C Watts SA Ogun AA Holder J Langhorne 2004 Disulfide bonds in merozoite surface protein 1 of the malaria parasite impede efficient antigen processing and affect the in vivo antibody response Eur J Immunol 34 639 648 10.1002/eji.200324514 1:CAS:528: DC%2BD2cXitlGgtr8%3D 14991593 (Pubitemid 39255911)
45. SI Mannering LC Harrison NA Williamson JS Morris DJ Thearle KP Jensen TW Kay J Rossjohn BA Falk GT Nepom AW Purcell 2005 The insulin A-chain epitope recognized by human T cells is posttranslationally modified J Exp Med 202 1191 1197 10.1084/jem.20051251 1:CAS:528:DC%2BD2MXht1Sntr%2FO 16260488 (Pubitemid 41586950)
46. W Chen JW Yewdell RL Levine JR Bennink 1999 Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants J Exp Med 189 1757 1764 10.1084/jem.189.11.1757 1:CAS:528:DyaK1MXjvVSnurc%3D 10359579 (Pubitemid 29272692)
47. MA Haque JW Hawes JS Blum 2001 Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition J Immunol 166 4543 4551 1:CAS:528:DC%2BD3MXit1Okt7Y%3D 11254711
48. T Shimizu A Watanabe M Ogawara H Mori T Shirasawa 2000 Isoaspartate formation and neurodegeneration in Alzheimer's disease Arch Biochem Biophys 381 225 234 10.1006/abbi.2000.1955 1:CAS:528:DC%2BD3cXmsFems78%3D 11032409 (Pubitemid 32260308)
49. HA Doyle RJ Gee MJ Mamula 2007 Altered immunogenicity of isoaspartate containing proteins Autoimmunity 40 131 137 10.1080/08916930601165180 1:CAS:528:DC%2BD2sXntlWnt7o%3D 17453712
50. HA Doyle J Zhou MJ Wolff BP Harvey RM Roman RJ Gee RA Koski MJ Mamula 2006 Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity J Biol Chem 281 32676 32683 10.1074/jbc.M604847200 1:CAS:528:DC%2BD28XhtFSrtrzL 16950786 (Pubitemid 46036823)
51. H Arentz-Hansen R Korner O Molberg H Quarsten W Vader YM Kooy KE Lundin F Koning P Roepstorff LM Sollid SN McAdam 2000 The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase J Exp Med 191 603 612 10.1084/jem.191.4.603 1:CAS:528:DC%2BD3cXhsVKqs7k%3D 10684852 (Pubitemid 30691413)
52. KN Henderson JA Tye-Din HH Reid Z Chen NA Borg T Beissbarth A Tatham SI Mannering AW Purcell NL Dudek DA van Heel J McCluskey J Rossjohn RP Anderson 2007 A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease Immunity 27 23 34 10.1016/j.immuni.2007.05.015 1:CAS:528:DC%2BD2sXosFeqtr4%3D 17629515 (Pubitemid 47090246)
53. CY Kim H Quarsten E Bergseng C Khosla LM Sollid 2004 Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease Proc Natl Acad Sci U S A 101 4175 4179 10.1073/pnas.0306885101 1:CAS:528: DC%2BD2cXivFart78%3D 15020763 (Pubitemid 38405902)
54. J Herzog Y Maekawa TP Cirrito BS Illian ER Unanue 2005 Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells Proc Natl Acad Sci U S A 102 7928 7933 10.1073/pnas.0502255102 1:CAS:528:DC%2BD2MXkvF2ju78%3D 15901898 (Pubitemid 40781040)
55. MI Aguilar AW Purcell R Devi R Lew J Rossjohn AI Smith P Perlmutter 2007 Beta-amino acid-containing hybrid peptides-new opportunities in peptidomimetics Org Biomol Chem 5 2884 2890 10.1039/b708507a 1:CAS:528:DC%2BD2sXps1Gkt7w%3D 17728852 (Pubitemid 47340677)
56. AI Webb MA Dunstone W Chen MI Aguilar Q Chen H Jackson L Chang L Kjer-Nielsen T Beddoe J McCluskey J Rossjohn AW Purcell 2004 Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue J Biol Chem 279 23438 23446 10.1074/jbc.M314066200 1:CAS:528:DC%2BD2cXkt1Git7Y%3D 15004033 (Pubitemid 38685654)
57. JG Kenna H Satoh DD Christ LR Pohl 1988 Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane J Pharmacol Exp Ther 245 1103 1109 1:CAS:528:DyaL1cXks1KktbY%3D 3385639